News and Trends 24 May 2016
Danish ‘safer’ vaccine for Smallpox gets US order worth €90M
Bavarian Nordic will receive €90M from the US’ BARDA for its nonreplicating smallpox vaccine – which can be administered to people with conditions like HIV. Bavarian Nordic is one of the Copenhagen-based Biotechs you need to know which is developing cancer immunotherapies and vaccines against infectious diseases. Its infectious disease programme is based on their vaccine technology which uses an […]